Literature DB >> 10393058

HLA-B27 subtypes and HLA class II alleles in Japanese patients with anterior uveitis.

Y Konno1, J Numaga, N Tsuchiya, A Ogawa, S M Islam, M Mochizuki, H Mitsui, H Oda, H Maeda.   

Abstract

PURPOSE: Some patients with anterior uveitis (AU) have ankylosing spondylitis (AS) and are HLA-B27 class I-positive. The purpose of this study was to investigate whether there are differences in HLA at the allele level among each group of patients with AU.
METHODS: Seventy-three patients with AU were studied. They were classified into three groups: 31 with AS-associated AU, 14 with HLA-B27-associated AU, and 28 with idiopathic AU. Three control groups without AU were used: 138 random subjects, 33 HLA-B27-positive healthy subjects, and 19 HLA-B27-positive patients with AS. DRB1 and DQB1 genotyping was performed using polymerase chain reaction (PCR)-single-strand conformation polymorphism (PCR-SSCP) and PCR-restriction fragment length polymorphism. HLA-B27 subtype was determined by PCR-SSCP.
RESULTS: There was no difference in the frequency of any class I antigen except HLA-B27 among the patients studied. The frequencies of HLA-DR12 in AS-associated AU and HLA-DR1 in HLA-B27-associated AU showed an increase. In HLA-B27-associated AU, DRB1*0101 and DQB1*0501 were increased compared with HLA-B27-positive control subjects. When HLA-B27 subtype distribution was compared among the groups, the proportion of B*2704 was significantly lower in HLA-B27-associated AU (P = 0.037), however, such a difference was not present in AS-associated groups.
CONCLUSIONS: These results indicated that B*2704 seemed to be less susceptible to AU compared with B*2705 in Japanese subjects. The increase of HLA-DR12 and HLA-DR1 in AU may be caused by linkage disequilibrium with B*2704 and B*2705, respectively.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10393058

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

1.  HLA-B27-associated acute anterior uveitis in the University Referral Centre in North Thailand: clinical presentation and visual prognosis.

Authors:  K Pathanapitoon; S Suksomboon; P Kunavisarut; S Ausayakhun; S Wattananikorn; N Leetrakool; A Rothova
Journal:  Br J Ophthalmol       Date:  2006-08-09       Impact factor: 4.638

2.  Characterization and outcome of uveitis in 350 patients with spondyloarthropathies.

Authors:  Percival D Sampaio-Barros; Roseneide A Conde; Rubens Bonfiglioli; Manoel B Bértolo; Adil M Samara
Journal:  Rheumatol Int       Date:  2006-09-07       Impact factor: 2.631

3.  CFH 184G as a genetic risk marker for anterior uveitis in Chinese females.

Authors:  Ming-ming Yang; Timothy Y Y Lai; Pancy O S Tam; Sylvia W Y Chiang; Carmen K M Chan; Fiona O J Luk; Tsz Kin Ng; Chi-Pui Pang
Journal:  Mol Vis       Date:  2011-10-13       Impact factor: 2.367

4.  The Rate of Helicobacter pylori Seropositivity in a Group of Korean Patients with HLA-B27-Associated Acute Anterior Uveitis.

Authors:  Jeong Hun Bae; Joon Mo Kim
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

Review 5.  T Cell-Mediated Chronic Inflammatory Diseases Are Candidates for Therapeutic Tolerance Induction with Heat Shock Proteins.

Authors:  Ariana Barbera Betancourt; Qingkang Lyu; Femke Broere; Alice Sijts; Victor P M G Rutten; Willem van Eden
Journal:  Front Immunol       Date:  2017-10-26       Impact factor: 7.561

6.  CFH I62V as a Putative Genetic Marker for Posner-Schlossman Syndrome.

Authors:  Ming Ming Yang; Hong Yan Sun; Ting Meng; Shan Hu Qiu; Qi Qiao Zeng; Tsz Kin Ng; Li Jiang; Ting Ming Deng; Ai Neng Zeng; Jun Wang; Xiao Ling Luo
Journal:  Front Immunol       Date:  2021-02-11       Impact factor: 7.561

7.  Human leukocyte antigen class II DRB1*1302 allele protects against cervical cancer: At which step of multistage carcinogenesis?

Authors:  Koji Matsumoto; Hiroo Maeda; Akinori Oki; Naoyoshi Takatsuka; Toshiharu Yasugi; Reiko Furuta; Ranko Hirata; Akira Mitsuhashi; Kei Kawana; Takuma Fujii; Takashi Iwata; Yasuo Hirai; Masatoshi Yokoyama; Nobuo Yaegashi; Yoh Watanabe; Yutaka Nagai; Hiroyuki Yoshikawa
Journal:  Cancer Sci       Date:  2015-09-25       Impact factor: 6.716

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.